Ye J, Xu J, Zhang C, Zhu L, Xia S
Front Immunol. 2023; 14:1081793.
PMID: 36761732
PMC: 9904206.
DOI: 10.3389/fimmu.2023.1081793.
Hurler L, Toonen E, Kajdacsi E, van Bree B, Brandwijk R, de Bruin W
Front Immunol. 2022; 13:1039765.
PMID: 36420270
PMC: 9677118.
DOI: 10.3389/fimmu.2022.1039765.
Vercauteren K, Lambrecht S, Delanghe J
Biochem Med (Zagreb). 2019; 29(3):030701.
PMID: 31379459
PMC: 6610672.
DOI: 10.11613/BM.2019.030701.
Martini F, Eckmair B, Stefanic S, Jin C, Garg M, Yan S
Nat Commun. 2019; 10(1):75.
PMID: 30622255
PMC: 6325117.
DOI: 10.1038/s41467-018-07948-7.
Yates M, Settle S, Yocum S, Aggarwal P, Vickery L, Aguiar D
Cartilage. 2015; 1(1):43-54.
PMID: 26069535
PMC: 4440612.
DOI: 10.1177/1947603509359189.
Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.
Venkatraman Girija U, Gingras A, Marshall J, Panchal R, Sheikh M, Harper J
Proc Natl Acad Sci U S A. 2013; 110(34):13916-20.
PMID: 23922389
PMC: 3752233.
DOI: 10.1073/pnas.1311113110.
C1q nephropathy in the pediatric population: pathology and pathogenesis.
Wenderfer S, Swinford R, Braun M
Pediatr Nephrol. 2010; 25(8):1385-96.
PMID: 20180137
DOI: 10.1007/s00467-009-1429-x.
The first component of human complement (C1): activation and control.
Ziccardi R
Springer Semin Immunopathol. 1983; 6(2-3):213-30.
PMID: 6314572
DOI: 10.1007/BF00205874.
Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution.
Boyd J, Burton D, Perkins S, Villiers C, Dwek R, Arlaud G
Proc Natl Acad Sci U S A. 1983; 80(12):3769-73.
PMID: 6304736
PMC: 394133.
DOI: 10.1073/pnas.80.12.3769.
Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
Chesne S, Villiers C, Arlaud G, Lacroix M, Colomb M
Biochem J. 1982; 201(1):61-70.
PMID: 6282262
PMC: 1163609.
DOI: 10.1042/bj2010061.
The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.
Rees D, Jones I, Handford P, Walter S, Esnouf M, Smith K
EMBO J. 1988; 7(7):2053-61.
PMID: 3262057
PMC: 454485.
DOI: 10.1002/j.1460-2075.1988.tb03045.x.
Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.
Arlaud G, Willis A, Gagnon J
Biochem J. 1987; 241(3):711-20.
PMID: 3036070
PMC: 1147622.
DOI: 10.1042/bj2410711.
Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.
Journet A, Tosi M
Biochem J. 1986; 240(3):783-7.
PMID: 3030286
PMC: 1147487.
DOI: 10.1042/bj2400783.
Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.
Villiers C, Arlaud G, Colomb M
Proc Natl Acad Sci U S A. 1985; 82(13):4477-81.
PMID: 2989825
PMC: 391124.
DOI: 10.1073/pnas.82.13.4477.
Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.
Gagnon J, Arlaud G
Biochem J. 1985; 225(1):135-42.
PMID: 2983658
PMC: 1144561.
DOI: 10.1042/bj2250135.
Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.
Lacroix M, Aude C, Arlaud G, Colomb M
Biochem J. 1989; 257(3):885-91.
PMID: 2539098
PMC: 1135670.
DOI: 10.1042/bj2570885.
